Correction: Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial (Journal of the American College of Cardiology (2017) 69(4) (381–391)(S0735109716371224)(10.1016/j.jacc.2016.10.068));Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial

Journal of the American College of Cardiology

Volumn 69, Issue 4, 2017, Pages 381-391

  Muller, David W M ^a,k   Farivar, Robert Saeid ^b,k   Jansz, Paul ^a,k   Bae, Richard ^b,k   Walters, Darren ^c,k   Clarke, Andrew ^c,k   Grayburn, Paul A ^d   Stoler, Robert C ^d   Dahle, Gry ^e,k   Rein, Kjell Arne ^e,k   Shaw, Marty ^a,k   Scalia, Gregory M ^c   Guerrero, Maya ^k   Pearson, Paul ^f,k   Kapadia, Samir ^g,k   Gillinov, Marc ^g,k   Pichard, Augusto ^h,k   Corso, Paul ^h,k   Popma, Jeffrey ^i,k   Chuang, Michael ^i,k   Blanke, Philippe ^j,k   Leipsic, Jonathon ^j,k   Sorajja, Paul ^b,k   Conellan, Mark ^k   Spina, Roberto ^k   Pedersen, Wesley ^k   Sun, Benjamin ^k   Scalia, Gregory ^k   Grayburn, Paul ^k   Stoler, Robert ^k   Hebeler, Robert ^k   Fiane, Arnt ^k   Feldman, Ted ^k   Salinger, Michael ^k   Smart, Steven ^k   Mick, Stephanie ^k   Krishnaswamy, Amar ^k   Carroll, John ^k   George, Isaac ^k   Missov, Emil ^k   Kiser, Andrew ^k   more..

^a ST VINCENT S HOSPITAL   (Australia)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f EVANSTON HOSPITAL   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h WASHINGTON HOSPITAL CENTER   (United States)

ⁱ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^j ST PAUL S HOSPITAL   (Canada)

^k NONE

more..

Author keywords

heart failure; mitral prosthesis; mitral regurgitation; mitral valve implantation; transcatheter

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMOLYSIS; HUMAN; MALE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PROSTHESIS THROMBOSIS; TRANSCATHETER MITRAL VALVE REPLACEMENT; TRANSTHORACIC ECHOCARDIOGRAPHY; CATHETERIZATION; ECHOCARDIOGRAPHY; FEASIBILITY STUDY; HEART VALVE REPLACEMENT; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CATHETERIZATION; ECHOCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 85009343073     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.01.020     Document Type: Erratum

References (39)

1. 1 Iung, B., Baron, G., Butchart, E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24 (2003), 1231–1243.
2. 2 Nkomo, V.T., Gardin, J.M., Skelton, T.N., Gottdiener, J.S., Scott, C.G., Enriquez-Sarano, M., Burden of valvular heart diseases: a population-based study. Lancet 368 (2006), 1005–1011.
3. 3 Asgar, A.W., Mack, M.J., Stone, G.W., Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65 (2015), 1231–1248.
4. 4 Grigioni, F., Enriquez-Sarano, M., Zehr, K.J., Bailey, K.R., Tajik, A.J., Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001), 1759–1764.
5. 5 Tribouilloy, C., Rusinaru, D., Grigioni, F., et al. Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: a multicenter analysis. Circ Cardiovasc Imaging 7 (2014), 363–370.
6. 6 Trochu, J.N., Le Tourneau, T., Obadia, J.F., Caranhac, G., Beresniak, A., Economic burden of functional and organic mitral valve regurgitation. Arch Cardiovasc Dis 108 (2015), 88–96.
7. 7 Bach, D.S., Awais, M., Gurm, H.S., Kohnstamm, S., Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol 54 (2009), 860–865.
8. 8 Mirabel, M., Iung, B., Baron, G., et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J 28 (2007), 1358–1365.
9. 9 Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2438–2488.
10. 10 Vahanian, A., Alfieri, O., Andreotti, F., et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33 (2012), 2451–2496.
11. 11 Goel, S.S., Bajaj, N., Aggarwal, B., et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol 63 (2014), 185–186.
12. 12 De Backer, O., Piazza, N., Banai, S., et al. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv 7 (2014), 400–409.
13. 13 Deeb, G.M., Reardon, M.J., Chetcuti, S., et al. 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 67 (2016), 2565–2574.
14. 14 Leon, M.B., Smith, C.R., Mack, M., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
15. 15 Smith, C.R., Leon, M.B., Mack, M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364 (2011), 2187–2198.
16. 16 Abdul-Jawad Altisent, O., Dumont, E., Dagenais, F., et al. Initial experience of transcatheter mitral valve replacement with a novel transcatheter mitral valve: procedural and 6-month follow-up results. J Am Coll Cardiol 66 (2015), 1011–1019.
17. 17 Cheung, A., Webb, J., Verheye, S., et al. Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol 64 (2014), 1814–1819.
18. 18 Maisano, F., Alfieri, O., Banai, S., et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?. Eur Heart J 36 (2015), 1651–1659.
19. 19 Moat, N., Duncan, A., Lindsay, A., et al. Transcatheter mitral valve replacement for the treatment of mitral regurgitation: in-hospital outcomes of an apically tethered device. J Am Coll Cardiol 65 (2015), 2352–2353.
20. 20 Blanke, P., Dvir, D., Cheung, A., et al. Mitral annular evaluation with CT in the context of transcatheter mitral valve replacement. J Am Coll Cardiol Img 8 (2015), 612–615.
21. 21 Stone, G.W., Adams, D.H., Abraham, W.T., et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: Part 2: endpoint definitions: a consensus document from the Mitral Valve Academic Research Consortium. J Am Coll Cardiol 66 (2015), 308–321.
22. 22 Stone, G.W., Vahanian, A.S., Adams, D.H., et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: Part 1: clinical trial design principles: a consensus document from the Mitral Valve Academic Research Consortium. J Am Coll Cardiol 66 (2015), 278–307.
23. 23 Mehran, R., Rao, S.V., Bhatt, D.L., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 (2011), 2736–2747.
24. 24 Rankin, J.S., Feneley, M.P., Hickey, M.S., et al. A clinical comparison of mitral valve repair versus valve replacement in ischemic mitral regurgitation. J Thorac Cardiovasc Surg 95 (1988), 165–177.
25. 25 Milano, C.A., Daneshmand, M.A., Rankin, J.S., et al. Survival prognosis and surgical management of ischemic mitral regurgitation. Ann Thorac Surg 86 (2008), 735–744.
26. 26 Goldstein, D., Moskowitz, A.J., Gelijns, A.C., et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med 374 (2016), 344–353.
27. 27 Lim, D.S., Reynolds, M.R., Feldman, T., et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation following transcatheter mitral valve repair with the MitraClip system. J Am Coll Cardiol 64 (2014), 182–192.
28. 28 Maisano, F., Taramasso, M., Nickenig, G., et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J 37 (2016), 817–825.
29. 29 Nickenig, G., Estevez-Loureiro, R., Franzen, O., et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. J Am Coll Cardiol 64 (2014), 875–884.
30. 30 Sorajja, P., Mack, M., Vemulapalli, S., et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol 67 (2016), 1129–1140.
31. 31 Nickenig, G., Schueler, R., Dager, A., et al. Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system. J Am Coll Cardiol 67 (2016), 2927–2936.
32. 32 Feldman, T., Kar, S., Elmariah, S., et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 66 (2015), 2844–2854.
33. 33 Buzzatti, N., De Bonis, M., Denti, P., et al. What is a “good” result after transcatheter mitral repair? Impact of 2+ residual mitral regurgitation. J Thorac Cardiovasc Surg 151 (2016), 88–96.
34. 34 Suri, R.M., Clavel, M.A., Schaff, H.V., et al. Effect of recurrent mitral regurgitation following degenerative mitral valve repair: long-term analysis of competing outcomes. J Am Coll Cardiol 67 (2016), 488–498.
35. 35 Kramer, D.G., Trikalinos, T.A., Kent, D.M., Antonopoulos, G.V., Konstam, M.A., Udelson, J.E., Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol 56 (2010), 392–406.
36. 36 Konstam, M.A., Kramer, D.G., Patel, A.R., Maron, M.S., Udelson, J.E., Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. J Am Coll Cardiol Img 4 (2011), 98–108.
37. 37 Butnaru, A., Shaheen, J., Tzivoni, D., Tauber, R., Bitran, D., Silberman, S., Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation. Am J Cardiol 112 (2013), 1439–1444.
38. 38 Makkar, R.R., Fontana, G., Jilaihawi, H., et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373 (2015), 2015–2024.
39. 39 De Marchena, E., Mesa, J., Pomenti, S., et al. Thrombus formation following transcatheter aortic valve replacement. J Am Coll Cardiol Intv 8 (2015), 728–739.